Temozolomide Chronotherapy for High Grade Glioma

NCT02781792 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Glioblastoma Multiforme

Interventions

DRUG: Temozolomide
OTHER: Functional Assessment of Cancer Therapy - Brain
OTHER: ActTrust Condor Instrument Watch

Sponsor

Washington University School of Medicine